Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Outsourcing
Almac details headquarters expansion plans
by Rick Mullin
November 9, 2023
| A version of this story appeared in
Volume 101, Issue 37
Almac has published details of a $98 million investment program that will expand its pharmaceutical and diagnostic service units with manufacturing and laboratory assets at its headquarters in Craigavon, Northern Ireland. Plans include a 9,300 m2 production facility supporting oral dosage drugs and a 3,700 m2 development center with diagnostic kit manufacturing facilities. Alma, which has set a recruitment goal of 1,000 new staffers in Northern Ireland over 3 years, says this expansion will create more than 550 jobs.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter